IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

May 2005 (Vol: 2005, Issue: 59)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
The Maturing of Biotech Published: 1 May-2005
By: Fintan Walton
Abstract Fulltext:
Section: Company Profile
ALTANA Pharma AG Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Deal Trackers
Alvesco (ciclesonide) Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Competition Forces Organon and J&J to Terminate Co-Promotion of Risperdal® Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
Pfizer Validates Coley Pharmaceutical's ProMune#8482; with Deal Worth US$515 M Plus Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Abbott Takes First Pick at BioCurex Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Deal Making Trends of Top Pharma Companies Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Erectile Dysfunction Published: 1 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Gilead Begins to Fill the Hole in its Pipeline Published: 5 May-2005
By: Business Review Editor
Abstract
Section: Licensing
Arakis and Vectura in COPD Alliance with Novartis Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Tanox to Buy Sunol Tissue Factor Assets Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Solvay Looks to Fournier to Expand Drugs Business Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
IDM’s and Epimmune’s Merger Highlights Biotech Funding Difficulties Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Curis and Genentech Join Forces Again Published: 5 May-2005
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in